World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
31964
World Ranking
1156
National Ranking
100

Medicine

D-Index
88
Citations
31964
World Ranking
13049
National Ranking
1218

Paul Moss publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul Moss sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 398 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul Moss D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul Moss sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paul Moss is affiliated with the University of Birmingham in the United Kingdom. Their research primarily focuses on the field of Medicine, with particular emphasis on Infectious Diseases, Immunology, Oncology, Neurology, and Health.

They have contributed significantly to the study of SARS-CoV-2 and COVID-19, with extensive work in related areas such as COVID-19 clinical research studies, long-term effects of COVID-19, COVID-19 epidemiological studies, vaccine coverage and hesitancy, CAR-T cell therapy research, and immune cell function and interaction.

Their recent publications include the following papers:

  • The T cell immune response against SARS-CoV-2, 2022, Nature Immunology
  • Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection, 2021, Nature Immunology
  • Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection, 2021, Nature Immunology
  • Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study, 2021, The Lancet Infectious Diseases
  • Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study, 2023, The Lancet Regional Health - Europe

Paul Moss collaborates frequently with several coauthors, including Jianmin Zuo, Gokhan Tut, Rachel Bruton, Hayden Pearce, and Maria Krutikov. These collaborations reflect an active engagement with other researchers across diverse aspects of infectious disease and immunology research.

The scientist's work is published often in notable venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • Research Square (Research Square)
  • Blood
  • Nature Immunology

The breadth of their research topics covers:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • COVID-19 epidemiological studies
  • Vaccine Coverage and Hesitancy
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction

Paul Moss's published work spans over 300 contributions in medicine, demonstrating sustained involvement in infectious diseases and immunology, with emerging intersections into oncology, neurology, and health research domains.

Best Publications

  • Phenotypic Analysis of Antigen-Specific T Lymphocytes

    John D. Altman;Paul A. H. Moss;Philip J. R. Goulder;Dan H. Barouch

  • Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals

    Naeem Khan;Naseer Shariff;Mark Cobbold;Rachel Bruton

  • Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers

    Mark Cobbold;Naeem Khan;Batoul Pourgheysari;Sudhir Tauro

  • Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

    Rachael A Evans;Hamish McAuley;Ewen M Harrison;Aarti Shikotra

  • Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells

    Martin Hewison;Lisa Freeman;Susan V. Hughes;Katie N. Evans

  • Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

    Karl S Peggs;Stephanie Verfuerth;Arnold Pizzey;Naeem Khan

  • Large clonal expansions of CD8 + T cells in acute infectious mononucleosis

    Margaret F.C. Callan;Neil Steven;Pete Krausa;Jamie D.K. Wilson

  • Functional Heterogeneity and High Frequencies of Cytomegalovirus-Specific CD8+ T Lymphocytes in Healthy Seropositive Donors

    Geraldine M. A. Gillespie;Mark R. Wills;Victor Appay;Chris O'Callaghan

  • Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery

    Suparno Chakrabarti;Vivien Mautner;Vivien Mautner;Husam Osman;Husam Osman;Kathryn E Collingham;Kathryn E Collingham

  • The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age.

    R. Gregg;C. M. Smith;F. J. Clark;D. Dunnion

  • Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia

    Oliver Goodyear;Angelo Agathanggelou;Igor Novitzky-Basso;Shamyla Siddique

  • Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

    Oliver C. Goodyear;Mike Dennis;Nadira Y. Jilani;Nadira Y. Jilani;Justin Loke

  • Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

    G S Ogg;X Jin;S Bonhoeffer;P Moss

  • Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia

    Tatjana Stankovic;Peter Weber;Grant Stewart;Tina Bedenham

  • Herpesvirus-Specific CD8 T Cell Immunity in Old Age: Cytomegalovirus Impairs the Response to a Coresident EBV Infection

    Naeem Khan;Andrew Hislop;Nancy Gudgeon;Mark Cobbold

  • Immunodeficiency and immunotherapy in multiple myeloma

    Guy Pratt;Oliver Goodyear;Paul Moss

  • The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo

    Victoria J. Weston;Ceri E. Oldreive;Anna Skowronska;David G. Oscier

  • CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions

    Michal Zimmermann;Olga Murina;Martin A. M. Reijns;Angelo Agathanggelou

  • Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

    Jianmin Zuo;Alexander C Dowell;Hayden Pearce;Kriti Verma

  • Perturbation of the normal immune system in patients with CLL

    Francesco Forconi;Paul Moss

  • Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.

    T. Mutis;G. Gillespie;E. Schrama;J.H.F. Falkenburg

  • Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.

    Kate Cwynarski;Jenni Ainsworth;Jenni Ainsworth;Mark Cobbold;Mark Cobbold;Simon Wagner;Simon Wagner

Frequent Co-Authors

Charles Craddock
Charles Craddock Queen Elizabeth Hospital Birmingham
John I. Bell
John I. Bell Ellison Institute of Technology
Jos A. Bosch
Jos A. Bosch University of Amsterdam
Andrew J. McMichael
Andrew J. McMichael University of Oxford
Alan B. Rickinson
Alan B. Rickinson University of Birmingham
Mark D. Kilby
Mark D. Kilby University of Birmingham
Grant S. Stewart
Grant S. Stewart University of Birmingham
Andrew I. Bell
Andrew I. Bell University of Birmingham
David Oscier
David Oscier Royal Bournemouth Hospital
Donald Milligan
Donald Milligan University of Birmingham

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare roles offer diverse opportunities for specialization and growth. Many students explore nursing pathways as a practical complement to immunological studies. Programs with easy admission LPN programs provide a streamlined entry into patient care, serving as a strong foundation for further clinical expertise.

Advancing within nursing careers, individuals often consider the easiest nurse practitioner degree programs. These programs balance accessibility with quality education, enabling students to build critical skills relevant to immunological and healthcare practice.

For those focused on mental health and psychiatric care, the best PMHNP programs online offer robust clinical placement opportunities. These programs emphasize hands-on experience ideal for understanding immune-related conditions affecting mental health.

Affordability is a key concern for many students. The cheapest PMHNP programs combine cost-effectiveness with comprehensive education, making advanced psychiatric nursing degrees more accessible.

Choosing the right program depends on factors like admission ease, clinical experience, and budget. These diverse pathways highlight how immunology connects with broader healthcare professions.

Best Scientists Citing Paul Moss

Trending Scientists

Recently Published Articles